Insulet announced positive data from the first feasibility study of its hybrid closed-loop system for adults with Type 1 diabetes.
Biotronik has received FDA approval for a bare-metal stent designed to treat coronary artery disease.
From startups to leading global companies, Greater Fort Lauderdale provides a stimulating and supportive business environment for success in the life sciences.
Livongo Health has struck a deal to offer Voluntis’ insulin dose recommendation medical device as part of its diabetes management service.
Integra LifeSciences has made a binding offer to acquire Johnson & Johnson’s Codman Neurosurgery business for about $1.05 billion in cash.
An aging population, an ever increasing amount of time viewing digital devices and a growing trend in eye diseases are all factors expected to fuel a global…
Medtronic has secured FDA clearance to market its OsteoCool RF Ablation System as a palliative treatment for metastatic bone tumors.
GluSense, which is developing a long-term glucose-monitoring implant, has received approximately $1.9 million from the newly launched JDRF T1D Fund.
Diagnostics player Hologic is diving into medical aesthetics with an acquisition of Cynosure worth approximately $1.65 billion.
Medtronic unveiled three new additions to its coronary portfolio to facilitate the treatment of coronary artery disease via the radial artery in the wrist.
University of Michigan scientists have adapted a microscopy technique to accelerate and automate the analysis of brain tissue during tumor removal surgery.
The United Kingdom’s cost watchdog has supported the use of HeartFlow FFRct Analysis to assess patients with stable, recent onset chest pain.